A new study found that using two blood tests can dramatically reduce the risk of delayed diagnosis in overweight children. Researchers discovered that a combination of hemoglobin A1C and oral glucose tolerance tests could catch more high-risk patients, missing nearly 2/3 with just one test.
PlasmaButton therapy offers a new treatment option for benign prostatic hyperplasia (BPH), with benefits including excellent tissue ablation, minimal patient morbidity, and ease of use. The technology provides a virtually bloodless procedure, reducing complications such as urinary tract infections and renal failure.
A new study reviewing over 74,000 births found that a key measure of body fat composition in newborns increased significantly alongside pregnant mothers' body mass index from 1990 to 2005. Health care providers are advised to pay closer attention to pregnant women's BMI before pregnancy and weight gain during pregnancy.
Researchers at Children's Mercy Hospitals and Clinics are developing a genetic test to predict hyperbilirubinemia, which causes 85% of hospital readmissions in newborns. The test also identifies genetic markers that determine the effectiveness of steroid therapy for asthma patients.